Cost-effectiveness of antiretroviral therapy for prevention
Date
2011
Authors
Kahn J.G.
Marseille E.A.
Bennett R.
Williams B.G.
Granich R.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
Keywords
antiretrovirus agent, cotrimoxazole, didanosine, efavirenz, lamivudine, lopinavir plus ritonavir, nevirapine, stavudine, tenofovir, acute phase response, cost benefit analysis, cost effectiveness analysis, disease transmission, epidemic, health care cost, highly active antiretroviral therapy, human, Human immunodeficiency virus infection, intervention study, morbidity, population model, quality adjusted life year, review, sexual transmission, tuberculosis
Citation
Current HIV Research
9
6
http://www.scopus.com/inward/record.url?eid=2-s2.0-80055081690&partnerID=40&md5=38fca75397bdb29f1ecef666c581dea8
9
6
http://www.scopus.com/inward/record.url?eid=2-s2.0-80055081690&partnerID=40&md5=38fca75397bdb29f1ecef666c581dea8